Blog

»  Posts By   August 2019 

Frier Levitt Successfully has Patient Neglect Charges Dropped for RN

Frier Levitt recently represented a Registered Nurse who was charged with patient neglect at a residency for the cognitively impaired. After working with the prosecutor, Frier Levitt was able to prove the charges were unsubstantiated and the prosecutor agreed to drop all charges against our client. Frier Levitt routinely represents healthcare professionals facing allegations of neglect and misconduct. Contact Frier Levitt today to speak to an attorney.

Pharmacies Should Not Ignore These Prescription “Red Flags”

In the midst of the opioid epidemic, regulators have become increasingly focused on prescriptions that are not issued for a legitimate medical purpose. Pharmacies should be aware of the "red flags" or warning signs that may indicate the presence of a fraudulent or forged prescription, as the DEA and various state Boards of Pharmacy have revoked controlled substances permits and pharmacy licenses for pharmacies that have failed to resolve red...

Frier Levitt Helps Pharmacy Reverse PBM Termination

Frier Levitt recently reversed a PBM's decision to terminate a pharmacy due to alleged drug invoice shortage discrepancies. The pharmacy was terminated due to the results of a PBM's pre-credentialing audit that failed to take into account a variety of purchases made during and prior to the audit period. The PBM also failed to take into account an inventory that was purchased from the previous owner of the pharmacy. Using...

Frier Levitt Negotiates Access to PBM Network for Previously Denied Pharmacy

Frier Levitt recently negotiated a contract with a PBM network for a pharmacy that had been denied entry on several previous occasions. The pharmacy had applied for a contract numerous times and was denied for various reasons for more than a year, eventually seeking legal assistance from Frier Levitt. Frier Levitt intervened and through application of in-depth knowledge of legal requirements and the PBM application process, assisted the pharmacy to...

NJ Client ALERT: Gabapentin Prescribing Receiving Higher Scrutiny Under New Evidence of Abuse

On May 7, 2018, the New Jersey Division of Consumer Affairs began requiring pharmacies begin reporting prescriptions for the unscheduled drug gabapentin to the New Jersey Prescription Monitoring Program (PMP). The drug, known under brand names Neurontin and Gralise, is currently unscheduled. However Michigan, Ohio, Kentucky, and West Virginia have all reclassified gabapentin as Schedule V, while other states are currently debating whether to schedule gabapentin as well. It has...